Form 4: ZoomInfo General Counsel Sells Shares Post-RSU Vesting

Sentiment:

Insider Transaction Report


ZoomInfo Technologies Inc.'s General Counsel, Ashley McGrane, reported the sale of common stock following the vesting of restricted stock units, executed under a Rule 10b5-1 trading plan.

Summary

  • Ashley McGrane, General Counsel and Corporate Secretary of ZoomInfo Technologies Inc., reported transactions involving common stock.
  • On October 1, 2025, McGrane acquired a total of 6,413 shares of common stock through the vesting of Restricted Stock Units (RSUs).
  • Concurrently, 1,885 shares were disposed of on October 1, 2025, at a price of $10.91 per share, to cover tax liabilities associated with the RSU vesting.
  • An additional 87 shares were sold on October 1, 2025, at a weighted average price of $10.675.
  • On October 2, 2025, 1,811 shares were sold at a weighted average price of $10.3939.
  • All reported sales were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
  • Following these transactions, McGrane beneficially owns 19,213 shares of common stock and 59,771 Restricted Stock Units across various grants.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the transactions were pre-planned under a Rule 10b5-1 plan, mitigating concerns about opportunistic selling. The filing is a routine disclosure of compensation-related stock activity.

Positives

  • The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned sales and reducing concerns about opportunistic insider trading.
  • The vesting of Restricted Stock Units represents a positive compensation event for the reporting person.

Negatives

  • Insider selling, even if planned, can sometimes be perceived negatively by the market, suggesting a desire to diversify or a lack of conviction, though mitigated by the 10b5-1 plan.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports past insider transactions.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions and does not provide information relevant to broader industry trends or competitive landscape analysis. It reflects individual compensation and portfolio management activities.

Stakeholder Impact

  • Shareholders: Minor impact due to routine insider selling, which is transparently disclosed. The pre-planned nature of the sales under a 10b5-1 plan reduces potential negative interpretations.
  • Employees: No direct impact mentioned, but RSU vesting is a common form of employee compensation.

Next Steps

  • Continued vesting of remaining Restricted Stock Units according to their respective schedules.

Key Dates

DateDescription
2023-03-23Original grant date for a tranche of Restricted Stock Units, vesting quarterly over 27 months starting January 1, 2025.
2023-10-25Original grant date for a tranche of Restricted Stock Units, vesting quarterly over 33 months starting January 1, 2025.
2024-03-26Original grant date for a tranche of Restricted Stock Units, vesting 25% on April 1, 2025, and the remainder quarterly over 36 months thereafter.
2024-07-24Original grant date for a tranche of Restricted Stock Units, vesting 25% on April 1, 2025, and the remainder quarterly over 36 months thereafter.
2025-01-01Start date for vesting of certain Restricted Stock Units.
2025-04-01Start date for vesting of other Restricted Stock Units.
2025-10-01Date of RSU vesting, tax withholding, and initial stock sales.
2025-10-02Date of additional stock sales.
2025-10-03Signature date of the Form 4 filing.

Recommendation

hold

This Form 4 filing reports routine insider transactions, specifically the vesting of Restricted Stock Units and subsequent sales for tax purposes and portfolio management, all executed under a Rule 10b5-1 trading plan. Such filings provide transparency but typically do not offer new fundamental information about the company's operations, financial health, or future prospects that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, as the filing does not present new catalysts for significant price movement or a re-evaluation of the company's intrinsic value.

Keywords

ZoomInfo Technologies Inc., GTM, Ashley McGrane, Insider Trading, Form 4, Restricted Stock Units, Rule 10b5-1 Plan, Equity Sales, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.